Biopharmaceutical R&D expenditure (multi-year total)

Total capital expenditure invested by biopharmaceutical companies into research and development of new medicines.

Unit billion USD Industry Pharmaceuticals

Records
1
Regions
1
Period
2015–2024
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Biopharmaceutical R&D expenditure (multi-year total)

United States, 2015–2024

1 observation
900 billion USD United States · 2015–2024 · PhRMA · full record
Source: PhRMA · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2015–2024

Biopharmaceutical R&D expenditure (multi-year total): every record, grouped by region, newest first.
Period Value Source Type
United States 1 record
2015–2024 900 billion USD PhRMA · 31 Dec 2024 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
Research & Development PhRMA 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Biopharmaceutical R&D expenditure (multi-year total). Retrieved from https://statorigin.org/indicators/biopharmaceutical-r-d-expenditure-multi-year-total